Advances in the development of a methylation assay for FSHD

Autor: Calandra P.1, Cascino I.1, Lemmers R.J.2, Teveroni E.1, 3, Ricci E.4, Galluzzi G.1, Monforte M.4, Tasca G.5, Moretti F.1, van der Maarel S.M.2, Deidda G.1

Publikováno v: FSH Society Facioscapulohumeral Muscular Dystrophy [FSHD] 2015 International Research Consortium & Research Planning Meetings, Boston, MA 02210 USA, October 5-6, 2015
info:cnr-pdr/source/autori:Calandra P.1, Cascino I.1, Lemmers R.J.2, Teveroni E.1,3, Ricci E.4, Galluzzi G.1, Monforte M.4, Tasca G.5, Moretti F.1, van der Maarel S.M.2, Deidda G.1/congresso_nome:FSH Society Facioscapulohumeral Muscular Dystrophy [FSHD] 2015 International Research Consortium & Research Planning Meetings/congresso_luogo:Boston, MA 02210 USA/congresso_data:October 5-6, 2015/anno:2015/pagina_da:/pagina_a:/intervallo_pagine

Facioscapulohumeral muscular dystrophy is a disease linked to an epigenetic defect in the chromosome 4q subtelomere. This dystrophy is caused by contraction of the D4Z4 macrosatellite array on chromosome 4qter in FSHD1, or by functional impairment of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::da9616f13a9455c57bf7060d3382c891
https://publications.cnr.it/doc/363484